Hugh Rosen is of Regulus Therapeutics Inc.. Currently has a direct ownership of 64,271 shares of RGLS, which is worth approximately $503,241. The most recent transaction as insider was on Apr 30, 2025, when has been sold 62,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 64.3K
n/a 3M change
n/a 12M change
Total Value Held $503,241

Hugh Rosen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 30 2025
BUY
Grant, award, or other acquisition
-
62,500 Added 49.3%
64,271 Common Stock
HR

Hugh Rosen

San Diego, CA

Track Institutional and Insider Activities on RGLS

Follow Regulus Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

News

Receive news related to Regulus Therapeutics Inc.

Track Activities on RGLS